Cargando…

A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia

Homozygous familial hypercholesterolemia (HoFH), the severest form of familial hypercholesterolemia (FH), is characterized by very high LDL-cholesterol levels and a high frequency of coronary heart disease. The disease is caused by the presence of either a pathogenic variant at homozygous status or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Taranto, Maria Donata, Giacobbe, Carola, Buonaiuto, Alessio, Calcaterra, Ilenia, Palma, Daniela, Maione, Giovanna, Iannuzzo, Gabriella, Di Minno, Matteo Nicola Dario, Rubba, Paolo, Fortunato, Giuliana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019873/ https://www.ncbi.nlm.nih.gov/pubmed/31947532 http://dx.doi.org/10.3390/jcm9010219

Ejemplares similares

Genetic spectrum of familial hypercholesterolemia and correlations with clinical expression: Implications for diagnosis improvement
por: Di Taranto, Maria Donata, et al.
Publicado: (2021)

Identification and in vitro characterization of two new PCSK9 Gain of Function variants found in patients with Familial Hypercholesterolemia
por: Di Taranto, Maria Donata, et al.
Publicado: (2017)

Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials
por: Di Minno, Alessandro, et al.
Publicado: (2020)

Genetic Heterogeneity of Familial Hypercholesterolemia: Repercussions for Molecular Diagnosis
por: Di Taranto, Maria Donata, et al.
Publicado: (2023)

Pathophysiological Role of Synovitis in Hemophilic Arthropathy Development: A Two-Hit Hypothesis
por: Calcaterra, Ilenia, et al.
Publicado: (2020)

An Untargeted Lipidomic Analysis Reveals Depletion of Several Phospholipid Classes in Patients with Familial Hypercholesterolemia on Treatment with Evolocumab
por: Anesi, Andrea, et al.
Publicado: (2021)

Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)

Long-term efficacy of lipoprotein apheresis and lomitapide in the treatment of homozygous familial hypercholesterolemia (HoFH): a cross-national retrospective survey
por: D’Erasmo, Laura, et al.
Publicado: (2021)

Case Report: Genetic Analysis of PEG-Asparaginase Induced Severe Hypertriglyceridemia in an Adult With Acute Lymphoblastic Leukaemia
por: Iannuzzi, Arcangelo, et al.
Publicado: (2022)

Volanesorsen to treat severe hypertriglyceridaemia: A pooled analysis of randomized controlled trials
por: Calcaterra, Ilenia, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia
por: Parihar, Ravi Kumar, et al.
Publicado: (2012)

Homozygous Familial Hypercholesterolemia
por: Nohara, Atsushi, et al.
Publicado: (2021)

Treatment with PCSK9 Inhibitors in Patients with Familial Hypercholesterolemia Lowers Plasma Levels of Platelet-Activating Factor and Its Precursors: A Combined Metabolomic and Lipidomic Approach
por: Di Minno, Alessandro, et al.
Publicado: (2021)

Association between body shape index and small dense LDL particles in a cohort of mediterranean women: findings from Progetto ATENA
por: Gentile, Marco, et al.
Publicado: (2017)

Galectin-3 in Cardiovascular Diseases
por: Blanda, Valeria, et al.
Publicado: (2020)

Xanthoma tuberosum in homozygous familial hypercholesterolemia
por: Moorthy, Nagaraja, et al.
Publicado: (2014)

Liver Transplantation for Homozygous Familial Hypercholesterolemia
por: Ishigaki, Yasushi, et al.
Publicado: (2019)

Treatment of Homozygous Familial Hypercholesterolemia With Evinacumab
por: Jeraj, Natasha, et al.
Publicado: (2021)

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia
por: Bajaj, Archna, et al.
Publicado: (2022)

Lipoprotein(a) Where Do We Stand? From the Physiopathology to Innovative Terapy
por: Iannuzzo, Gabriella, et al.
Publicado: (2021)

Effects of Bisphosphonate Treatment on Circulating Lipid and Glucose Levels in Patients with Metabolic Bone Disorders
por: Iannuzzo, Gabriella, et al.
Publicado: (2021)

Genetic screening for homozygous and heterozygous familial hypercholesterolemia
por: Izar, Maria C, et al.
Publicado: (2010)

Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia
por: Ito, Matthew K., et al.
Publicado: (2015)

Homozygous familial hypercholesterolemia with an update on cholesterol management
por: Velvet, Anju J J, et al.
Publicado: (2020)

New algorithms for treating homozygous familial hypercholesterolemia
por: Tromp, Tycho R., et al.
Publicado: (2022)

Current Treatment Options in Homozygous Familial Hypercholesterolemia
por: Kayikcioglu, Meral, et al.
Publicado: (2022)

Hemostatic Changes in Patients with COVID-19: A Meta-Analysis with Meta-Regressions
por: Di Minno, Matteo Nicola Dario, et al.
Publicado: (2020)

Rare variants in PKHD1 associated with Caroli syndrome: Two case reports
por: Giacobbe, Carola, et al.
Publicado: (2022)

Novel Presentation of Homozygous Familial Hypercholesterolemia With Homozygous Variants in Both LDLR and APOB Genes
por: Derenbecker, Robert, et al.
Publicado: (2019)

Homozygous Familial Hypercholesterolemia: Case Series and Review of the Literature
por: Palacio, Carlos H., et al.
Publicado: (2011)

Homozygous Familial Hypercholesterolemia Associated with Symmetric Subcutaneous Lipomatosis
por: Dawoud, Noha Mohammed, et al.
Publicado: (2015)

Premature Valvular Heart Disease in Homozygous Familial Hypercholesterolemia
por: Fahed, Akl C., et al.
Publicado: (2017)

Calprotectin Levels and Neutrophil Count Are Prognostic Markers of Mortality in COVID-19 Patients
por: Cardiero, Giovanna, et al.
Publicado: (2022)

Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey
por: Walzer, S, et al.
Publicado: (2013)

Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous Familial Hypercholesterolemia
por: Harada-Shiba, Mariko, et al.
Publicado: (2017)

Evidence-Based, Mechanistic Approach to the Management of Homozygous Familial Hypercholesterolemia
por: Rosenson, Robert S.
Publicado: (2022)

Homozygous Familial Hypercholesterolemia: Luck Meets Opportunity Meets Knowledge
por: Young, Lisa, et al.
Publicado: (2022)

Treatment of Homozygous Familial Hypercholesterolemia With ANGPTL3 Inhibitor, Evinacumab
por: Shamsudeen, Isabel, et al.
Publicado: (2023)

Multiple Xanthoma Tuberosum in a Case of Familial Homozygous Hypercholesterolemia
por: Singhania, Pankaj, et al.
Publicado: (2022)

Short-term evolocumab-induced tendon xanthomas regression in an elderly patient with homozygous familial hypercholesterolemia
por: Cicero, Arrigo F. G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_t29n3ger2euhc9e3km0b2udqj1